Schedule 13G ownership disclosure
NABRIVA THERAPEUTICS PLC
Security class unavailable · CUSIP: G63637105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,801,333
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-19-002502
- Form type
- SC 13G
- Filer
- Nabriva Therapeutics plc
- CIK
- CIK 1641640
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership